Stock listing

Cellavision Ab

Selected listing: A0NEVD · LS · EUR · DE

Cellavision Ab (Lang & Schwarz: A0NEVD), Health Technology. Latest release Jun 5, 2026: The Board of CellaVision AB appoints Steve Ferguson as CEO.

A0NEVD:LSEURDEUpdated October 3, 2026

Ticker: Lang & Schwarz: A0NEVD
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Lang & Schwarz
Currency: EUR

About Cellavision Ab

The company specializes in digital pathology solutions, enhancing the efficiency of medical diagnostics. Cellavision focuses on developing innovative technologies to improve laboratory workflows and patient care.

Latest news from Cellavision Ab

The Board of CellaVision AB appoints Steve Ferguson as CEO

June 5, 2026

CellaVision publishes its 2025 Annual and Sustainability Report

April 1, 2026

CellaVision appoints Monica Jönsson as new CFO

December 12, 2025

CellaVision receives CE marking according to IVDR Class C for CellaVision® Bone Marrow Aspirate Application

December 8, 2025

CellaVision : appoints Monica Jönsson as Interim CFO

September 2, 2025

All Cellavision Ab news →

Events

Replays

CellaVision AB (publ) (CEVI) Q2 2026 Earnings Call
Fri, Jul 17, 2026 · 05:00 AM ET
Watch
CellaVision AB (publ) (CEVI) Q1 2026 Earnings Call
Fri, Apr 24, 2026 · 05:00 AM ET
Watch
CellaVision AB (publ) (CEVI) Q4 2025 Earnings Call
Thu, Feb 05, 2026 · 05:00 AM ET
Watch

Research Cellavision Ab

Cellavision Ab company profile

View the public company page for Cellavision Ab on 6ix.

Cellavision Ab news

Read company news and market updates connected to Cellavision Ab.

Cellavision Ab investor events

Find investor webinars, events, and replay context for Cellavision Ab.